From the Journals

Doctors prescribe fewer statins in the afternoon


 

Why the variability?

“The nudge unit uses prompts to ask the physician about prescribing statins. The question is, what is causing the variability in statin prescriptions?” Nieca Goldberg, MD, medical director of the New York University women’s heart program, said in an interview.

Dr. Nieca Goldberg, medical director of the NYU Langone Womens' Heart Program, New York City

Dr. Nieca Goldberg

“Is it fatigue, lack of familiarity of guidelines, or is this due to the volume of patients and lack of time to discuss the therapy and make a shared decision with their patient? The answer to these questions was not part of the study,” said Dr. Goldberg, who is also an American Heart Association volunteer expert. “It would be interesting to know the thoughts of the physicians who were studied after they were informed of the results. Also, having a nudge to write the prescription will increase the prescriptions of statins, but will patients take the medication?”

The study was funded in part by a grant from the National Institute on Aging. Ms. Hare and Dr. Goldberg reported no relevant financial relationships.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Remote cardio visits expand access for underserved during COVID
Journal of Clinical Outcomes Management
Severe obesity persists, takes high cardiovascular toll
Journal of Clinical Outcomes Management
PTSD linked to ischemic heart disease
Journal of Clinical Outcomes Management
COVID plus MI confers poor prognosis; 1 in 3 die in hospital
Journal of Clinical Outcomes Management
Post–COVID-19 cardiac involvement in college athletes much rarer than thought
Journal of Clinical Outcomes Management
A ‘mess’ of a diagnosis: Is it type 2 MI or a nonischemic imposter?
Journal of Clinical Outcomes Management
Hypertension worsened by commonly used prescription meds
Journal of Clinical Outcomes Management
A simple new definition for ‘metabolically healthy obesity’?
Journal of Clinical Outcomes Management
Finerenone scores second pivotal-trial success in patients with diabetic kidney disease
Journal of Clinical Outcomes Management
FDA blazes path for ‘real-world’ evidence as proof of efficacy
Journal of Clinical Outcomes Management